Ocular Therapeutix
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 |
|---|---|---|---|---|
Revenue | $16,440 | $14,715 | $14,802 | $14,950 |
Gross Profit | 14,931 | 13,389 | 13,416 | 13,573 |
EBITDA | -42,634 | -31,617 | -19,091 | -19,214 |
EBIT | -43,590 | -32,537 | -20,049 | -20,104 |
Net Income | -43,777 | -64,848 | -29,220 | -516 |
Net Change In Cash | 16,440 | 14,715 | 14,802 | 14,950 |
Free Cash Flow | -25,544 | -34,142 | -17,729 | -7,991 |
Cash | 459,690 | 483,038 | 195,957 | 110,550 |
Basic Shares | 165,824 | 132,021 | 84,429 | 85,142 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $58,443 | $51,494 | $43,522 | $17,403 |
Gross Profit | 53,162 | 46,954 | 39,116 | 15,320 |
EBITDA | -79,399 | -77,857 | -78,003 | -62,679 |
EBIT | -82,382 | -79,966 | -80,424 | -65,452 |
Net Income | -80,736 | -63,422 | -10,804 | -159,631 |
Net Change In Cash | 58,443 | 51,494 | 43,522 | 17,403 |
Cost of Revenue | -61,864 | -63,893 | 173,619 | |
Free Cash Flow | -76,321 | -63,318 | -66,744 | -54,395 |
Cash | 195,957 | 102,300 | 164,164 | 228,057 |
Basic Shares | 85,596 | 76,875 | 82,162 | 60,752 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-06-30 | -$0.26 |
2024-03-31 | -$0.70 |
2023-12-31 | -$0.35 |
2023-09-30 | -$0.17 |
